Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over ...

CI's Q3 results are likely to be aided by strength in the specialty pharmacy business, partly offset by elevated medical ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Ballad Health and Cigna are working to finalize negotiations as a New Year’s Eve deadline looms to keep some of the insurance ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

The remarks on a call with analysts signaled Cigna is focused on returning cash to shareholders rather than a possible deal ...

Over the last 10 months, the Congress government secured agreements for 140 Life Sciences or pharmaceutical projects ...

Cigna ( (CI) ) has released its Q3 earnings. Here is a breakdown of the information Cigna presented to its investors. The Cigna Group is a ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

Cigna operates through two primary segments: Cigna Healthcare and Evernorth Health Services. The company has demonstrated consistent growth, with analysts projecting long-term adjusted earnings ...